SF Cell Line 4D-Nucleofector® LV Kit L
SF Cell Line 4D-Nucleofector® LV Kit L
You May Also Need...
Product Overview
The SF Cell Line 4D-NucleofectorTM LV Kit L* is suited for larger scale transfection of cell lines in the 1 mL NucleocuvetteTM Cartridge format when working with the 4D-NucleofectorTM LV Unit. With the 1 mL NucleocuvetteTM Cartridge a fixed volume of 1 mL can be transfected. The cartridge is manually filled via a sterile injection port.
This kit has been determined to be optimal for transfecting following cell lines and many others that use Solution SF as optimal NucleofectorTM Solution:
- HEK293 suspension clones
- CHO-S suspension clones
- K-562
- U-937
The respective cell type-specific Optimized Protocols or recommendations are available under "Instructions" or in our knowledge database. In these Optimized Protocols the best Nucleofection conditions are indicated. In addition, we share our experience and knowledge for treatment of individual cell types.
*Note: From the three cell line solutions (SE, SF, SG) that come with the 4D-NucleofectorTM System only SF is available for the large-scale formats so far. Solution SF is suited for the vast majority of cell lines that might be used in larger scale applications (e.g. suspension CHO or 293 cells). For other solutions please contact our Scientific Support.
Request More InfoBenefits
- Closed Nucleofection of up to 108 cells
- Conditions transferable from existing smaller scale protocols
- Simple manual filling via sterile injection port
- Transfection with seconds
Applications
- For large scale transfection of up to 1 x 108 cells
- Transient production of potential therapeutic proteins or antibodies for construct screening
- Generation of large numbers of transiently modified cell lines for cell-based assays
Storage and Content
2.25 mL SF Cell Line NucleofectorTM Solution
0.5 mL Supplement 1
50 µg pmaxGFPTM Vector (1 μg/μl in 10 mM Tris pH 8.0)
2 x 1 mL NucleocuvetteTM Cartridge
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
-
4D-Nucleofector® Protocol for TF-1
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for TF-1 -
4D-Nucleofector® Protocol for A-375
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for A-375 -
4D-Nucleofector® Protocol for CCRF-CEM
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for CCRF-CEM -
4D-Nucleofector® Protocol for C6 Glioma
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for C6 Glioma -
4D-Nucleofector® Protocol for L428
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for L428 -
4D-Nucleofector® Protocol for FDC-P1
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for FDC-P1 -
4D-Nucleofector® Protocol for CHO-K1
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for CHO-K1 -
4D-Nucleofector® Protocol for EL4
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for EL4 -
4D-Nucleofector® Protocol for K562
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for K562 -
4D-Nucleofector® Protocol for HL-60
Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for HL-60
Lonza GS Xceed™ Cells transfected in small or larger scale show comparable IgG4 titers
For a human IgG4 antibody, similar titers of about 100 µg/mL were achieved in small scale (100 µl) and large scale transfections (1 ml fixed cartridge or 10 mL in flow through LV cartridge) in a 6-day batch culture without any feeds. IgG titers were increased by factor 2.5 when using higher seeding densities (not shown here). Switching to a 14-day fed-batch culture led to titers > 1 mg/mL (not shown here).
Transferability of Nucleofection® Conditions from Small to Large Scale
Expression of maxGFP® Protein in cells transfected in small volume (100 μL Nucleocuvette® Vessels) or larger volumes (1 mL or LV Nucleocuvette® Cartridge). Data represent the mean of various independent experiments.
